Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAmortization - GoodwillCost of RevenueEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetShares RepurchasedShort-Term Debt repayments
Ratios

Avanos Medical (AVNS) Accumulated Depreciation & Amortization (2016 - 2025)

Avanos Medical's Accumulated Depreciation & Amortization history spans 12 years, with the latest figure at $34.4 million for Q3 2024.

  • For Q3 2024, Accumulated Depreciation & Amortization fell 0.58% year-over-year to $34.4 million; the TTM value through Sep 2024 reached $34.4 million, down 0.58%, while the annual FY2023 figure was $46.1 million, 3.35% down from the prior year.
  • Accumulated Depreciation & Amortization for Q3 2024 was $34.4 million at Avanos Medical, up from $22.7 million in the prior quarter.
  • Across five years, Accumulated Depreciation & Amortization topped out at $47.7 million in Q4 2022 and bottomed at $9.7 million in Q1 2021.
  • The 5-year median for Accumulated Depreciation & Amortization is $23.6 million (2023), against an average of $26.5 million.
  • The largest annual shift saw Accumulated Depreciation & Amortization rose 26.63% in 2020 before it dropped 10.72% in 2021.
  • A 5-year view of Accumulated Depreciation & Amortization shows it stood at $42.9 million in 2020, then fell by 10.72% to $38.3 million in 2021, then rose by 24.54% to $47.7 million in 2022, then dropped by 3.35% to $46.1 million in 2023, then decreased by 25.38% to $34.4 million in 2024.
  • Per Business Quant, the three most recent readings for AVNS's Accumulated Depreciation & Amortization are $34.4 million (Q3 2024), $22.7 million (Q2 2024), and $11.4 million (Q1 2024).